Executives highlighted AI's transformative potential in healthcare when asked by MobiHealthNews how they see AI's place in the sector changing in 2025.
Some expect multimodal AI and advanced diagnostic imaging to make significant strides next year, while others showcased AI's promise in improving diagnostics, addressing provider burnout, automating tasks, streamlining drug development and...
MobiHealthNews queried health executives from across the digital health industry and asked them for their insights into key issues impacting health systems and patients.
In part two of this two-part series on the year's biggest takeaways, executives discuss topics ranging from smart monitors to advances in telehealth, wearables and the direct-to-consumer movement.
Amit Khanna, senior vice...
Digital health executives predict funding in 2024 will increase for companies with platforms proven helpful for healthcare providers and patients, while those not showing value will be forced to dissolve.
Leaders also relayed to MobiHealthNews that mergers and acquisitions will be prominent in the digital health industry, and genAI companies may take center stage when garnering funding. ...
Leaders in the digital health space told MobiHealthNews their predictions about where AI will make the most significant mark in healthcare in 2024.
Following the considerable increase in the use of AI in healthcare in 2023, stakeholders expect next year to bring even wider adoption of the technology across various sectors, from implementation in physician-facing tools that help ease provider...
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation.
The raise included returning investor Obvious Ventures and new participants La Maison and Top Harvest Capital. The company previously raised $14 million in Series A funding in 2020.
WHAT IT DOES
Inato offers a technology platform that connects pharma companies and potential clinical trial...
Inato, a Parisian startup revamping clinical trial enrollment, has pulled in a $14 million Series A round. Obvious Ventures and Cathay Innovation headed the raise, which also saw support from prior backers Serena and Fly Ventures.
WHAT THEY DO
Inato has developed a platform that helps biopharma clients select the optimal site for their clinical studies. Its technology incorporates logistical data...
